FNCL 8 1991 LB [BTBT] vs Morgan Stanley [MS] Detailed Stock Comparison
FNCL 8 1991 LB
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: FNCL 8 1991 LB wins in 4 metrics, Morgan Stanley wins in 12 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | FNCL 8 1991 LB | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.53 | 15.91 | FNCL 8 1991 LB |
| Price-to-Book Ratio | 1.54 | 2.33 | FNCL 8 1991 LB |
| Debt-to-Equity Ratio | 3.36 | 416.64 | FNCL 8 1991 LB |
| PEG Ratio | 22.93 | 17.71 | Morgan Stanley |
| EV/EBITDA | -15.50 | N/A | N/A |
| Profit Margin (TTM) | -77.90% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | -212.08% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | N/A | 34.12% | N/A |
| Return on Equity | -23.29% | 12.14% | Morgan Stanley |
| Return on Assets (TTM) | -11.70% | 1.05% | Morgan Stanley |
| Free Cash Flow (TTM) | $-106.99M | $-2.10B | FNCL 8 1991 LB |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | -4.84% | 49.18% | Morgan Stanley |
| Price-to-Sales Ratio (TTM) | 10.79 | 3.42 | Morgan Stanley |
| Enterprise Value | $619.61M | $135.62B | Morgan Stanley |
| EV/Revenue Ratio | 6.07 | 2.07 | Morgan Stanley |
| Gross Profit Margin (TTM) | 49.05% | N/A | N/A |
| Revenue per Share (TTM) | $1 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $-0.56 | $8.83 | Morgan Stanley |
| Beta (Stock Volatility) | 4.91 | 1.32 | Morgan Stanley |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
FNCL 8 1991 LB vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| FNCL 8 1991 LB | 1.27% | 1.37% | -15.23% | 46.77% | -4.53% | -5.45% |
| Morgan Stanley | 1.63% | -1.08% | -1.96% | 18.32% | 0.67% | 12.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| FNCL 8 1991 LB | -4.84% | 56.08% | -28.05% | -36.70% | -36.70% | -36.70% |
| Morgan Stanley | 49.18% | 54.16% | 170.17% | 271.35% | 445.56% | 167.36% |
Performance & Financial Health Analysis: FNCL 8 1991 LB vs Morgan Stanley
| Metric | BTBT | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.10B | $224.22B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 29,706,280 | 4,940,340 |
| 90 Day Avg. Volume | 56,959,797 | 5,738,320 |
| Last Close | $2.99 | $143.21 |
| 52 Week Range | $1.69 - $5.74 | $92.78 - $145.48 |
| % from 52W High | -47.95% | -1.56% |
| All-Time High | $33.00 (Jan 04, 2021) | $145.48 (Jul 30, 2025) |
| % from All-Time High | -90.94% | -1.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.18% | 0.11% |
| Quarterly Earnings Growth | -0.17% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.78% | 0.22% |
| Operating Margin (TTM) | -2.12% | 0.34% |
| Return on Equity (TTM) | -0.23% | 0.12% |
| Debt to Equity (MRQ) | 3.36 | 416.64 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.23 | $60.41 |
| Cash per Share (MRQ) | $0.28 | $343.53 |
| Operating Cash Flow (TTM) | $25.28M | $47.06B |
| Levered Free Cash Flow (TTM) | $-105,071,592 | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | N/A | $2.79 |
Valuation & Enterprise Metrics Analysis: FNCL 8 1991 LB vs Morgan Stanley
| Metric | BTBT | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.53 | 15.91 |
| Forward P/E | 22.93 | 17.71 |
| PEG Ratio | 22.93 | 17.71 |
| Price to Sales (TTM) | 10.79 | 3.42 |
| Price to Book (MRQ) | 1.54 | 2.33 |
| Market Capitalization | ||
| Market Capitalization | $1.10B | $224.22B |
| Enterprise Value | $619.61M | $135.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.07 | 2.07 |
| Enterprise to EBITDA | -15.50 | N/A |
| Risk & Other Metrics | ||
| Beta | 4.91 | 1.32 |
| Book Value per Share (MRQ) | $2.23 | $60.41 |
Financial Statements Comparison: FNCL 8 1991 LB vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BTBT | MS |
|---|---|---|
| Revenue/Sales | $25.11M | $16.52B |
| Cost of Goods Sold | $12.79M | N/A |
| Gross Profit | $12.31M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-3.16M | N/A |
| EBITDA | $53.62M | N/A |
| Pre-Tax Income | $-57.04M | $5.54B |
| Income Tax | $671,716 | $1.17B |
| Net Income (Profit) | $-57.71M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BTBT | MS |
|---|---|---|
| Cash & Equivalents | $57.56M | $60.84B |
| Total Current Assets | $188.02M | N/A |
| Total Current Liabilities | $48.25M | N/A |
| Long-Term Debt | $8.98M | $303.93B |
| Total Shareholders Equity | $417.42M | $107.85B |
| Retained Earnings | $-155.92M | $107.65B |
| Property, Plant & Equipment | $163.26M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BTBT | MS |
|---|---|---|
| Operating Cash Flow | $-34.10M | $-67.29B |
| Capital Expenditures | $-64.96M | $-713.00M |
| Free Cash Flow | $-47.56M | $-24.69B |
| Debt Repayment | N/A | $-20.85B |
| Common Stock Repurchase | N/A | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | BTBT | MS |
|---|---|---|
| Shares Short | 34.19M | 14.94M |
| Short Ratio | 0.62 | 2.51 |
| Short % of Float | 0.11% | 0.01% |
| Average Daily Volume (10 Day) | 29,706,280 | 4,940,340 |
| Average Daily Volume (90 Day) | 56,959,797 | 5,738,320 |
| Shares Outstanding | 179.13M | 1.61B |
| Float Shares | 204.00M | 1.22B |
| % Held by Insiders | 0.02% | 0.24% |
| % Held by Institutions | 0.24% | 0.63% |
Dividend Analysis & Yield Comparison: FNCL 8 1991 LB vs Morgan Stanley
| Metric | BTBT | MS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.79 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | N/A | $3.10 |
| 3-Year Avg Dividend Yield | N/A | 0.90% |
| 3-Year Total Dividends | N/A | $9.31 |
| Ex-Dividend Date | N/A | Jan 31, 2025 |